Teng C S, Ho P W, Yeung R T
J Clin Endocrinol Metab. 1982 Sep;55(3):524-30. doi: 10.1210/jcem-55-3-524.
Eighteen patients with postnecrotic cirrhosis of liver, including three patients who had had a portosystemic shunt operation, and 19 normal controls were studied. The tests performed included monocyte insulin receptor assay, iv glucose tolerance test, glucagon test, and insulin tolerance test. Insulin resistance was documented by the presence of fasting hyperglycemia and glucose intolerance together with hyperinsulinemia as well as resistance to exogenous insulin. The binding of [125I]insulin to monocyte insulin receptors was significantly decreased in cirrhotic patients compared with that in controls (P less than 0.02), and this was due to a significant decrease in the high affinity association constant (P less than 0.005). There was a significant negative correlation between the fasting insulin level and maximum [125I]insulin binding in cirrhotic patients (r = -0.8; P less than 0.02). Cirrhotics that had had a shunt operation showed a higher fasting insulin level, a greater insulin resistance, and a smaller maximum [125I]insulin binding to insulin receptors than those without shunt. All of these findings suggested a down-regulatory effect of hyperinsulinemia on the monocyte insulin receptors. An impaired glycemic response to glucagon was also found in cirrhotics, the exact mechanism of which remains to be elucidated. However, as the increases in plasma cAMP after glucagon were similar in cirrhotics and controls, the fault apparently did not lie in the glucagon receptor.
对18例坏死性肝硬化患者(包括3例曾接受门体分流手术的患者)和19名正常对照者进行了研究。所进行的检测包括单核细胞胰岛素受体测定、静脉葡萄糖耐量试验、胰高血糖素试验和胰岛素耐量试验。空腹高血糖、葡萄糖不耐受以及高胰岛素血症的存在,连同对外源性胰岛素的抵抗,均证明存在胰岛素抵抗。与对照组相比,肝硬化患者单核细胞胰岛素受体上[125I]胰岛素的结合显著减少(P<0.02),这是由于高亲和力结合常数显著降低所致(P<0.005)。肝硬化患者的空腹胰岛素水平与最大[125I]胰岛素结合之间存在显著负相关(r=-0.8;P<0.02)。接受分流手术的肝硬化患者比未接受分流手术的患者表现出更高的空腹胰岛素水平、更大的胰岛素抵抗以及更小的最大[125I]胰岛素与胰岛素受体的结合。所有这些发现提示高胰岛素血症对单核细胞胰岛素受体具有下调作用。在肝硬化患者中还发现对胰高血糖素的血糖反应受损,其确切机制尚待阐明。然而,由于肝硬化患者和对照组在胰高血糖素作用后血浆cAMP的升高相似,故缺陷显然不在于胰高血糖素受体。